Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-09
1999-04-06
Patterson, Jr., Charles L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530399, 424423, A61K 3827, C07K 1461
Patent
active
058918400
ABSTRACT:
Novel modified or derivatized recombinant animal somatotropins. Methods for stabilizing recombinant animal somatotropins by modification or deletion of the Cysteine residues utilizing site directed mutagenesis to replace from one to four of the cysteine amino acid residues of said somatotropins with one or more different amino acid residues or by derivatization of (1) both cysteine amino acid residues in the small loop of said somatotropin, both cysteine amino acid residues in the large loop or the four cysteine amino acid residues in both loops of said somatotropin.
REFERENCES:
patent: 4443539 (1984-04-01), Fraser et al.
patent: 4761289 (1988-08-01), Shalati et al.
patent: 4774091 (1988-09-01), Yamahira et al.
patent: 4959314 (1990-09-01), Mark et al.
patent: 5079230 (1992-01-01), Randawa et al.
Graf et al., FEBS LETTERS, 66(2):233-237 (Jul. 1976).
Bewley et al., Short Communications, Biochim. Biophys. Acta, 154:420-422 (1968).
A. Klibanov, "Stabilization of Enzymes Against Thermal Inactivation," Advances in Applied Microbiology, 29:14-15 and 22 (1983).
T. Bewley et al., Biochemistry, 8:4701-4708 (1969).
J. Mills et al., Annals New York Acad. Sci., 148:343-351 (1968).
Tokunaga et al., Eur. J. Biochem. 153:445-449 (1985).
Wang et al., Science, 224:1431-1433 (1984).
Graf et al., Int. J. Peptide Protein Res., 7:467-473 (1975).
Necessary et al., Biol. Abstract No. 80:002951, and Mol. Cell. Endocrinol., 39(3):247-254 (1985).
Creighton, Proteins: Structure and Molecular Properties, W.H. Freeman & Co., New York, (1984) pp. 1-24.
Seeburg et al., DNA, 2(1):37-45 (1983).
Wang et al., J. Parenteral Sci. & Tech., Supplement, vol. 42, 2S, Technical Report No. 10 (1988).
Kenney et al. (1986) Lymphokine Res. 5, 523-527.
Buckwalter Brian Lee
Cady Susan Mancini
Chaleff Deborah Tardy
Logan John Steele
Stockton Gerald William
American Cyanamid Company
Barker M. Paul
Hendricks Keith D.
Patterson Jr. Charles L.
Webster Darryl L.
LandOfFree
Stabilization of somatotropins by modification of cysteine resid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilization of somatotropins by modification of cysteine resid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilization of somatotropins by modification of cysteine resid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1371379